PEMBlog

MAY 1, 2025

Well break down the virology, epidemiology, clinical presentation, and complications of Parvovirus B19. Formulate an evidence-based management plan for patients with suspected or confirmed Parvovirus B19, including those with underlying hemolytic disease or immunocompromise. Centers for Disease Control and Prevention.

Complication 86

Complication Patient-Centered Patients Clinic 86

FDA Law Blog

FEBRUARY 29, 2024

According to documents in the PTO’s Patent Center, Lilly has not yet filed a response. ZYDELIG (idelalisib) remains approved for use “in combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL) for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.”

Clinic 59

Clinic IT Provider Patient-Centered 59

GeriPal

MARCH 7, 2024

There’s an organization that I took my training from, which began, I want to say, in 2012. Whenever I take care of a patient, I see myself as a family practice doctor, but I’ve been a hospitalist, I’ve been a primary care doctor, and I’ve done palliative. It’s been around for a while.

Provider 119

Provider Illness IT Healthcare 119